Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01747122
Other study ID # 2012/R/SU/01 - LIVER 2 Trial
Secondary ID
Status Completed
Phase N/A
First received November 28, 2012
Last updated October 13, 2014
Start date December 2012
Est. completion date August 2014

Study information

Verified date October 2014
Source University of Edinburgh
Contact n/a
Is FDA regulated No
Health authority Scotland: Academic and Clinical Central Office for Research and Development (ACCORD)
Study type Interventional

Clinical Trial Summary

The investigators plan to compare epidurals versus wound catheters for effects on pain relief and recovery following open liver surgery.


Recruitment information / eligibility

Status Completed
Enrollment 97
Est. completion date August 2014
Est. primary completion date August 2014
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Patients undergoing open hepatic resection for benign or malignant conditions.

Exclusion Criteria:

- Patients with contraindication to either epidural or wound catheter techniques.

- Inability to give written, informed consent.

- Jaundice (Bilirubin > 100 µmol/L)

- Liver resection combined with secondary surgical procedure.

- Age < 18 years

- Pregnant women

- patients on long term opiates for chronic pain

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Device:
Wound catheter
Wound catheter, placed at end of procedure, prior to closure. To be kept in for 48 hours.
Epidural


Locations

Country Name City State
United Kingdom Royal Infirmary of Edinburgh Edinburgh Lothian

Sponsors (2)

Lead Sponsor Collaborator
University of Edinburgh NHS Lothian

Country where clinical trial is conducted

United Kingdom, 

References & Publications (1)

Revie EJ, McKeown DW, Wilson JA, Garden OJ, Wigmore SJ. Randomized clinical trial of local infiltration plus patient-controlled opiate analgesia vs. epidural analgesia following liver resection surgery. HPB (Oxford). 2012 Sep;14(9):611-8. doi: 10.1111/j.1477-2574.2012.00490.x. Epub 2012 Jun 10. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Other Quality of Life (EQ-5D) Pre-operative, 2 weeks post-operative, 4-6 weeks post-operative No
Other Morphine consumption Day of surgery and postoperative days 1-7 No
Other IV Fluid volume Day of Surgery and postoperative days 1-7 No
Other Complications day of surgery and post-operative days 1-30 No
Other Post-operative blood tests (FBC, U&E, LFTs, coag) Post-operative days 1-7 No
Primary Length of stay Number of days (to nearest half day) patients stay in hospital. Measurement made on day of discharge which is expected to be on average bewteen 5 and 10 days after surgery. No
Secondary Pain Scores Visual analogue scores of pain experienced. Performed daily at 0900 hours. On the day of surgery pain scores will be performed at 2, 6 and 12 hours post surgery. No
Secondary Molecular response to surgery HMGB1, RAGE and cytokines Days 0, 1 and 3 No
Secondary Central Venous Pressure Mean Central Venous Pressure during liver transection will be quantified and compared between groups. During liver transection No
Secondary Estimated Blood Loss Intra-operative No
Secondary Operative field asessment During liver transection No
Secondary Pringle time Intra-operative No
See also
  Status Clinical Trial Phase
Not yet recruiting NCT03672357 - Short and Long Outcomes Between Laparoscopic and Open Hepatectomy N/A
Recruiting NCT03958825 - Open Versus Laparoscopic Left Hepatic Sectionectomy N/A